Millions more adults should consider starting cholesterol-lowering medications earlier to reduce their risk of heart attack and stroke, according to new medical guidance. In an updated guideline ...

Eleven medical organizations advised changes to preventive cardiac care that it says could markedly reduce heart attacks and ...

ACC/AHA guidance also gives boost to non-cholesterol tests ...

For primary prevention patients at high risk, such as those with a 10-year risk > 10%, the LDL target is less than 70 mg/dL (class 2a recommendation). For this group, treatment begins with a ...

The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high cholesterol, is part of new doctors' guidelines.

At the end of the study, those taking the drug had 21% lower LDL cholesterol levels than those taking a placebo. They also ...

High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...

Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one third of the adult population. This disorder is characterized by the ...

A prescription medication that has been available in the U.S. since 1992 might have another significant benefit.